BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

IntelGenx Corp. 

6425 Abrams Ville Street

Laurent  Quebec  H4S 1X9  Canada
Phone: 514-331-7440 Fax: 514-331-0436


SEARCH JOBS




Industry
Pharmaceutical






 Company News
IntelGenx Corp. Reports 2013 Annual Results And Provides Corporate Development Update 3/11/2014 9:09:32 AM    More...
IntelGenx Corp. And RedHill Biopharma Ltd. (RDHL) Submit Response To FDA CRL For Versafilm™ Product For Migraines 3/3/2014 8:49:54 AM    More...
IntelGenx Corp. Announces Receipt Of Two Additional U.S. Patent Allowances Related To Proprietary Technology 2/26/2014 9:08:41 AM    More...
IntelGenx Corp. Achieves Positive Bioequivalence Results For Erectile Dysfunction Versafilm™ Tadalafil Product 2/24/2014 8:49:13 AM    More...
IntelGenx Corp. Report Delivers Analyst Opinion And Fundamental Data 2/5/2014 5:32:46 AM    More...
FDA Denies IntelGenx Corp., RedHill Biopharma Ltd. (RDHL)'s Acute Migraine Drug 2/4/2014 7:01:21 AM    More...
IntelGenx Corp. Closes $3.5 Million Public Offering 12/17/2013 9:16:05 AM    More...
IntelGenx Corp. Announces Public Offering Of $3,500,000 Of Common Stock 12/12/2013 9:36:30 AM    More...
IntelGenx Corp. Grants Stock Options 12/5/2013 9:38:49 AM    More...
IntelGenx Corp. Receives Buprenorphine/Naloxone Sublingual Film Product Patent Infringement Complaint 8/27/2013 9:10:21 AM    More...
12345678910...